[Does the Leveen valve still have a place in the treatment of refractory ascites? An evaluation of 107 cases].
One hundred and seven patients have been treated by the peritoneovenous shunt (PVS) : 54 patients from 1979 to 1984 (P1) and 53 patients from 1985 to 1990 (P2). The mean age was 58 years (25-79 years) and 73 % of the patients had a cirrhosis of alcoholic origin. The mortalities at two weeks and one month were 22 % and 26 % for P1 and 6 % and 11 % for P2. The risk of operation was related to the importance of hepatic and kidney insufficiency and to the importance of hyponatremia. Long term outcome depended on the causal illness. At short term, the morbidity can be reduced and the PVS should be indicated earlier in the progression of the illness.
Stöckle
M
M
Hôpital Saint-André, Département d'anesthésie, Bordeaux.
Bruce
C
C
Stöckle
E
E
Lefebvre
P
P
Roche
A
A
Sabathié
M
M
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000453:epidemiology / Q000401:mortality / Q000601:surgery*; D008104:Liver Cirrhosis, Alcoholic / Q000453:epidemiology / Q000401:mortality / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010536:Peritoneovenous Shunt; D012189:Retrospective Studies; D016896:Treatment Outcome
La valve de Leveen dans le traitement de l'ascite réfractaire reste-t-elle d'actualité? Bilan de 107 cas.